Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
277
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Effects of Multi-Donor Fecal Microbiota Transplantation Capsules Combined with Thalidomide on Hormone-Dependent Ulcerative Colitis

Xiao-He GuoDepartment of Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, People’s Republic of ChinaView further author information
,
Yan-Li ZhuDepartment of Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Lu YangDepartment of Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, People’s Republic of ChinaView further author information
,
Wen-Jing LiDepartment of Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, People’s Republic of ChinaView further author information
&
Xue-Fang DuDepartment of Gastroenterology, the First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, People’s Republic of ChinaView further author information
Pages 7495-7501 | Received 08 Aug 2022, Accepted 14 Nov 2022, Published online: 19 Dec 2022

References

  • Harbord M, Eliakim R, Bettenworth D., et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. part 2: current management. J Crohn's Colitis. 2017;11(7):769–784. doi:10.1093/ecco-jcc/jjx009
  • Hoffmann P, Krisam J, Stremmel W, Gauss A. Real-world outcomes of vedolizumab therapy in ulcerative colitis and crohn’s disease at a tertiary referral center. Dig Dis. 2019;37(1):33–44. doi:10.1159/000492322
  • Costello SP, Hughes PA, Waters O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321(2):156–164. doi:10.1001/jama.2018.20046
  • Rossen NG, Fuentes S, van der Spek MJ, et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149(1):110–118.e4. doi:10.1053/j.gastro.2015.03.045
  • Yahui G, Weiwei N. Inflammatory bowel disease group, digestive branch, Chinese Medical Association Consensus on the diagnosis and treatment of inflammatory bowel disease (2018, Beijing). Chin J Digestion. 2018;38(5):292–311.
  • Kelly CR, Kahn S, Kashyap P, et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149(1):223–237. doi:10.1053/j.gastro.2015.05.008
  • Cui B, Li P, Xu L, et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015;13:298. doi:10.1186/s12967-015-0646-2
  • Xiaonan L, Fengrong Y, Xiaolan Z. Interpretation of the consensus on diagnosis and management of inflammatory bowel disease (Beijing, 2018) from the perspective of diagnosis of ulcerative colitis First. Clinical Focus. 2018;33(11):987–990.
  • Paramsothy S, Paramsothy R, Rubin DT, et al. Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis. 2017;11(10):1180–1199. doi:10.1093/ecco-jcc/jjx063
  • Shen ZH, Zhu CX, Quan YS, et al. Relationship between intestinal microbiota and ulcerative colitis: mechanisms and clinical application of probiotics and fecal microbiota transplantation. World J Gastroenterol. 2018;24(1):5–14. doi:10.3748/wjg.v24.i1.5
  • Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–1071. doi:10.1038/ajg.2014.133
  • De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013;11(8):1036–1038. doi:10.1016/j.cgh.2013.04.045
  • Zhu J, Zhang F, Zhou J, Li H. Assessment of therapeutic response in Crohn’s disease using quantitative dynamic contrast enhanced MRI (DCE-MRI) parameters: a preliminary study. Medicine. 2017;96(32):e7759. doi:10.1097/MD.0000000000007759
  • Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012;9(10):599–608. doi:10.1038/nrgastro.2012.152
  • Hui-jun SHU, Hong YANG, Zheng WANG. Efficacy and safety of thalidomide in the treatment of adult refractory ulcerative colitis. Chin J Practical Int Med. 2018;38(3):223–226.
  • Mizuno S, Nanki K, Matsuoka K, et al. Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients. Intest Res. 2017;15(1):68–74. doi:10.5217/ir.2017.15.1.68
  • Nishida A, Imaeda H, Ohno M, et al. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol. 2017;52(4):476–482. doi:10.1007/s00535-016-1271-4
  • Rossen NG, MacDonald JK, de Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol. 2015;21(17):5359–5371. doi:10.3748/wjg.v21.i17.5359
  • Zheng YY, Wang X, Si JT, et al. Randomized clinical trials of traditional Chinese medicines for treating ulcerative colitis: a scoping review. World J Tradit Chin Med. 2021;7:326–331. doi:10.4103/wjtcm.wjtcm_22_21

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.